Text

A Fusobacterium nucleatum vaccine to help protect against colorectal cancer?

Vaccines against F. nucleatum and other onco-microbes may help prevent diseases such as colorectal cancer.

IPA expands scope to include prebiotics, postbiotics and synbiotics

The International Probiotics Association’s expansion is part of the organization’s strategy to help the ’biotics’ industry grow in response to market demands.

Ferring Pharmaceuticals announces availability of REBYOTA™ by prescription in the United States

Rebyota is the first and only FDA-approved Microbiome-Based Treatment for the prevention of recurrence of C. diff infection in adults.

Iron availability can influence microbial communities in the gut

The findings of a recent study suggest that the availability of iron can reshape the composition of the gut microbiota in irreversible ways.

ADM expands probiotics and postbiotic production with Spain facility

Chicago-based company said it invested more than $30 million to help meet rising global demand

The microbiota may promote sensory neuron regeneration

The findings of a recent study suggest that the microbiota can promote neuronal repair after tissue damage.

Probiotics are Popular in Europe and the Guidance Comes from HCPs, IPA EU Survey said

Consumers would like to be more informed on the labelling and in communications about probiotic food, and about probiotic microorganisms in food and food supplements.

Some gut microbes may reverse diet-mediated protection against type 1 diabetes

The findings of a recent study may inform dietary interventions to help protect people against type 1 diabetes and other autoimmune diseases.

MD Anderson and Federation Bio Announce Collaboration to Develop Novel Microbiome Treatment for Patients with Immunotherapy-Resistant Cancers

Collaboration joins MD Anderson's expertise and capabilities with Fed Bio's proprietary ACT bacterial cell therapy platform to design and manufacture a complex, synthetic microbiome-based therapy

Study characterizes alterations of the gut microbiota in Crohn’s disease

The findings of a recent study advance our understanding of bacterial dysbiosis in Crohn’s disease and may inform new therapeutic strategies.

Subscribe to MicrobiomePost newsletter

Take full advantage of MicrobiomePost‘s features.

Scroll to Top